BioSpace News Archive

According to Vision Research Reports, the global topical drugs market was valued at USD 97.51 billion in 2021 and it is predicted to surpass around USD 217.9 billion by 2030 with a CAGR of 9.35% from 2022 to 2030.

According to Report Study, the India malaria diagnostics market was valued at USD 20.3 million in 2021 and it is predicted to surpass around USD 29.96 million by 2030 with a CAGR of 4.42% from 2022 to 2030.

The U.S. craniomaxillofacial devices market was estimated at USD 993.42 million in 2021 and it is expected to surpass around USD 2.27 billion by 2030, poised to grow at a CAGR of 9.62% from 2022 to 2030.

Athira Pharma, Inc. (NASDAQ: ATHA), announced that Hans Moebius, M.D., Ph.D., Athira’s Chief Medical Officer, is leading an oral presentation titled, “ACT-AD: Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease – First Results of a Randomized, Placebo-Controlled, 26-Week Phase 2 Proof-of-Concept Trial” today at the Alzheimer’s Association International Conference (AAIC) 2022.

Forecast to 2030,’ thoroughly examines the Herpes Simplex Treatment industry to provide essential data & information for the targeted readers.

Oxeia Biopharmaceuticals Inc., a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury, announced today the completion of an interim analysis of its ongoing Phase 2 clinical trial of OXE103 at the University of Kansas Medical Center.

Forecast to 2030,’ thoroughly examines the Hyperparathyroidism Treatment industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Hypokalemia industry to provide essential data & information for the targeted readers.

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its first quarter ended June 30, 2022, at 4:15 p.m. EST on Tuesday, August 9, 2022.

Forecast to 2030,’ thoroughly examines the Pulmonary Embolism Treatment industry to provide essential data & information for the targeted readers.